elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38746778-4770EE69-3611-4219-A1D8-C36253C85007
Q38746778-4770EE69-3611-4219-A1D8-C36253C85007
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38746778-4770EE69-3611-4219-A1D8-C36253C85007
Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms.
P2860
Q38746778-4770EE69-3611-4219-A1D8-C36253C85007
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38746778-4770EE69-3611-4219-A1D8-C36253C85007
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c37392a7f4ba18fa49c33dd3e31ecf17e186f96a
P2860
A phase I study of cabozantinib (XL184) in patients with renal cell cancer.